New research indicates that patients who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who stop traditional lifestyle programs.
Findings released in a leading health publication points out that while overweight people often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.
"People buying these medications should be cognizant of the risk of quick weight regain when the therapy concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to original mass in about a year and a half.
Analyzing Approaches
The research, which reviewed 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
The team point out that individuals who shed pounds through lifestyle changes alone usually have a slower weight regain—approximately 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists propose the mechanism of the jabs accounts for the amplified regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Disease?
The NHS suggest the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts contend that, due to the high risk of relapse, the therapy might need to be life-long.
This perspective is echoed by pharmaceutical companies, who state that the results "underscore the long-term nature of excess weight," similar to managing conditions like diabetes.
Patient Testimonies
Users who have stopped the jabs explain a intense resurgence of hunger.
"It was like a switch flipping and you become ravenous," described a patient.
The struggle is exacerbated if patients have not adopted permanent dietary or behavioural modifications during therapy.
Significant Interest
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is greater among women than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, experts caution that while these medications are potent agents for shedding pounds, they are not a magic fix and maintained weight loss relies on integrated lifestyle support.